Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

NCT00078312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy
Sleep Apnea, Obstructive
Sleep Apnea Syndromes
Shift-Work Sleep Disorder

Interventions

DRUG: CEP-10953 (Armodafinil)

Sponsor

Cephalon